Skip to Content

Logo (Actavis) 3117 Logo (Actavis) 3117 (Morphine Sulfate Extended-Release 75 mg)

Pill with imprint Logo (Actavis) 3117 Logo (Actavis) 3117 is Brown, Capsule-shape and has been identified as Morphine Sulfate Extended-Release 75 mg. It is supplied by Actavis Elizabeth LLC.

Morphine is used in the treatment of chronic pain; neonatal abstinence syndrome; pain and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy. Morphine 75 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Images for Logo (Actavis) 3117 Logo (Actavis) 3117

Morphine Sulfate Extended-Release

Logo (Actavis) 3117 Logo (Actavis) 3117
75 mg
Prescription only
Drug Class
Narcotic analgesics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
2 - High potential for abuse
Labeler / Supplier
Actavis Elizabeth LLC
National Drug Code (NDC)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.